IMS Pricing and Market Access (P&MA), formerly M-TAG Pty Ltd, is a market leader in providing health economics and outcomes research for Australian and regional clients. We deliver evidence-based consulting solutions that inform confident decision-making about pricing and market access issues.
Our consultants work across a broad range of therapeutic areas and are leaders in developing evidence-based solutions. Our in-depth industry knowledge and technical expertise, enriched by the power of IMS data means that we provide clients with real workable solutions. Our clients include government agencies, pharmaceutical, medical device and diagnostic technology companies.
IMS's experience in the Asia-Pacific region includes supporting drug reimbursement and providing and delivering health outcomes and pharmacoeconomic solutions. The diversity of cultural healthcare financing arrangements in our region create unique challenges and needs. We apply our technical skills and commercial strategic awareness to ensure best outcomes.
We have more than 15 years experience in developing pricing and market access strategies and working with regulators in many countries. Demonstrating product value can be a challenge. At IMS we apply our intelligence and creativity to deliver innovative local and global strategic insights that meet your needs.